annual D&A:
$43.71M+$89.00K(+0.20%)Summary
- As of today (June 22, 2025), TXG annual depreciation & amortization is $43.71 million, with the most recent change of +$89.00 thousand (+0.20%) on December 31, 2024.
- During the last 3 years, TXG annual D&A has risen by +$15.45 million (+54.70%).
- TXG annual D&A is now at all-time high.
Performance
TXG Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$9.81M-$750.00K(-7.10%)Summary
- As of today (June 22, 2025), TXG quarterly depreciation & amortization is $9.81 million, with the most recent change of -$750.00 thousand (-7.10%) on March 31, 2025.
- Over the past year, TXG quarterly D&A has dropped by -$1.68 million (-14.62%).
- TXG quarterly D&A is now -17.37% below its all-time high of $11.88 million, reached on June 30, 2023.
Performance
TXG quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$42.03M-$1.68M(-3.84%)Summary
- As of today (June 22, 2025), TXG TTM depreciation & amortization is $42.03 million, with the most recent change of -$1.68 million (-3.84%) on March 31, 2025.
- Over the past year, TXG TTM D&A has dropped by -$4.47 million (-9.61%).
- TXG TTM D&A is now -9.61% below its all-time high of $46.50 million, reached on March 31, 2024.
Performance
TXG TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TXG Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +0.2% | -14.6% | -9.6% |
| 3 y3 years | +54.7% | +23.1% | +41.2% |
| 5 y5 years | +518.6% | +130.4% | +308.4% |
TXG Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +54.7% | -17.4% | +23.1% | -9.6% | +41.2% |
| 5 y | 5-year | at high | +518.6% | -17.4% | +130.4% | -9.6% | +308.4% |
| alltime | all time | at high | +1019.3% | -17.4% | +847.3% | -9.6% | +3956.8% |
TXG Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $9.81M(-7.1%) | $42.03M(-3.8%) |
| Dec 2024 | $43.71M(+0.2%) | $10.56M(-1.7%) | $43.71M(-2.5%) |
| Sep 2024 | - | $10.75M(-1.4%) | $44.85M(-1.5%) |
| Jun 2024 | - | $10.90M(-5.2%) | $45.52M(-2.1%) |
| Mar 2024 | - | $11.49M(-1.8%) | $46.50M(+6.6%) |
| Dec 2023 | $43.62M(+32.2%) | $11.71M(+2.5%) | $43.62M(+8.0%) |
| Sep 2023 | - | $11.42M(-3.8%) | $40.38M(+8.9%) |
| Jun 2023 | - | $11.88M(+37.8%) | $37.08M(+10.2%) |
| Mar 2023 | - | $8.62M(+1.7%) | $33.65M(+1.9%) |
| Dec 2022 | $33.01M(+16.8%) | $8.47M(+4.4%) | $33.01M(+3.6%) |
| Sep 2022 | - | $8.12M(-3.9%) | $31.86M(+2.7%) |
| Jun 2022 | - | $8.44M(+5.9%) | $31.02M(+4.2%) |
| Mar 2022 | - | $7.97M(+8.9%) | $29.76M(+5.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $28.25M(+48.5%) | $7.32M(+0.7%) | $28.25M(+7.2%) |
| Sep 2021 | - | $7.28M(+1.2%) | $26.35M(+10.0%) |
| Jun 2021 | - | $7.19M(+11.1%) | $23.95M(+12.8%) |
| Mar 2021 | - | $6.47M(+19.4%) | $21.23M(+11.6%) |
| Dec 2020 | $19.02M(+169.2%) | $5.42M(+11.1%) | $19.02M(+15.6%) |
| Sep 2020 | - | $4.88M(+9.2%) | $16.45M(+20.8%) |
| Jun 2020 | - | $4.47M(+4.9%) | $13.61M(+32.3%) |
| Mar 2020 | - | $4.26M(+49.7%) | $10.29M(+45.6%) |
| Dec 2019 | $7.07M(+80.9%) | $2.85M(+39.4%) | $7.07M(+67.4%) |
| Sep 2019 | - | $2.04M(+78.4%) | $4.22M(+93.6%) |
| Jun 2019 | - | $1.14M(+10.4%) | $2.18M(+110.4%) |
| Mar 2019 | - | $1.04M | $1.04M |
| Dec 2018 | $3.90M(-9.3%) | - | - |
| Dec 2017 | $4.30M | - | - |
FAQ
- What is 10x Genomics annual depreciation & amortization?
- What is the all time high annual D&A for 10x Genomics?
- What is 10x Genomics annual D&A year-on-year change?
- What is 10x Genomics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for 10x Genomics?
- What is 10x Genomics quarterly D&A year-on-year change?
- What is 10x Genomics TTM depreciation & amortization?
- What is the all time high TTM D&A for 10x Genomics?
- What is 10x Genomics TTM D&A year-on-year change?
What is 10x Genomics annual depreciation & amortization?
The current annual D&A of TXG is $43.71M
What is the all time high annual D&A for 10x Genomics?
10x Genomics all-time high annual depreciation & amortization is $43.71M
What is 10x Genomics annual D&A year-on-year change?
Over the past year, TXG annual depreciation & amortization has changed by +$89.00K (+0.20%)
What is 10x Genomics quarterly depreciation & amortization?
The current quarterly D&A of TXG is $9.81M
What is the all time high quarterly D&A for 10x Genomics?
10x Genomics all-time high quarterly depreciation & amortization is $11.88M
What is 10x Genomics quarterly D&A year-on-year change?
Over the past year, TXG quarterly depreciation & amortization has changed by -$1.68M (-14.62%)
What is 10x Genomics TTM depreciation & amortization?
The current TTM D&A of TXG is $42.03M
What is the all time high TTM D&A for 10x Genomics?
10x Genomics all-time high TTM depreciation & amortization is $46.50M
What is 10x Genomics TTM D&A year-on-year change?
Over the past year, TXG TTM depreciation & amortization has changed by -$4.47M (-9.61%)